Found 2 hits for monomerid = 50277053 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277053
![PNG](/data/jpeg/tenK5027/BindingDB_50277053.png) (CHEMBL4174382)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C150H220N44O48S2/c1-70(2)50-94(131(225)174-93(45-49-244-9)130(224)181-100(57-112(156)207)140(234)193-118(73(6)199)121(157)215)176-134(228)99(55-80-61-165-86-27-17-16-26-84(80)86)180-129(223)92(41-44-111(155)206)175-146(240)117(71(3)4)192-138(232)97(51-76-22-12-10-13-23-76)179-135(229)101(58-114(209)210)182-128(222)91(40-43-110(154)205)169-122(216)72(5)168-125(219)88(29-20-47-163-149(158)159)170-126(220)89(30-21-48-164-150(160)161)172-143(237)106(66-197)188-137(231)103(60-116(213)214)184-145(239)108(68-243)190-133(227)96(54-79-33-37-83(203)38-34-79)177-127(221)87(28-18-19-46-151)171-142(236)105(65-196)187-132(226)95(53-78-31-35-82(202)36-32-78)178-136(230)102(59-115(211)212)183-144(238)107(67-198)189-148(242)120(75(8)201)194-139(233)98(52-77-24-14-11-15-25-77)185-147(241)119(74(7)200)191-113(208)63-166-124(218)90(39-42-109(153)204)173-141(235)104(64-195)186-123(217)85(152)56-81-62-162-69-167-81/h10-17,22-27,31-38,61-62,69-75,85,87-108,117-120,165,195-203,243H,18-21,28-30,39-60,63-68,151-152H2,1-9H3,(H2,153,204)(H2,154,205)(H2,155,206)(H2,156,207)(H2,157,215)(H,162,167)(H,166,218)(H,168,219)(H,169,216)(H,170,220)(H,171,236)(H,172,237)(H,173,235)(H,174,225)(H,175,240)(H,176,228)(H,177,221)(H,178,230)(H,179,229)(H,180,223)(H,181,224)(H,182,222)(H,183,238)(H,184,239)(H,185,241)(H,186,217)(H,187,226)(H,188,231)(H,189,242)(H,190,227)(H,191,208)(H,192,232)(H,193,234)(H,194,233)(H,209,210)(H,211,212)(H,213,214)(H4,158,159,163)(H4,160,161,164)/t72-,73+,74+,75+,85-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-/m0/s1 | PDB MMDB
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| KEGG PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046 BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277053
![PNG](/data/jpeg/tenK5027/BindingDB_50277053.png) (CHEMBL4174382)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C150H220N44O48S2/c1-70(2)50-94(131(225)174-93(45-49-244-9)130(224)181-100(57-112(156)207)140(234)193-118(73(6)199)121(157)215)176-134(228)99(55-80-61-165-86-27-17-16-26-84(80)86)180-129(223)92(41-44-111(155)206)175-146(240)117(71(3)4)192-138(232)97(51-76-22-12-10-13-23-76)179-135(229)101(58-114(209)210)182-128(222)91(40-43-110(154)205)169-122(216)72(5)168-125(219)88(29-20-47-163-149(158)159)170-126(220)89(30-21-48-164-150(160)161)172-143(237)106(66-197)188-137(231)103(60-116(213)214)184-145(239)108(68-243)190-133(227)96(54-79-33-37-83(203)38-34-79)177-127(221)87(28-18-19-46-151)171-142(236)105(65-196)187-132(226)95(53-78-31-35-82(202)36-32-78)178-136(230)102(59-115(211)212)183-144(238)107(67-198)189-148(242)120(75(8)201)194-139(233)98(52-77-24-14-11-15-25-77)185-147(241)119(74(7)200)191-113(208)63-166-124(218)90(39-42-109(153)204)173-141(235)104(64-195)186-123(217)85(152)56-81-62-162-69-167-81/h10-17,22-27,31-38,61-62,69-75,85,87-108,117-120,165,195-203,243H,18-21,28-30,39-60,63-68,151-152H2,1-9H3,(H2,153,204)(H2,154,205)(H2,155,206)(H2,156,207)(H2,157,215)(H,162,167)(H,166,218)(H,168,219)(H,169,216)(H,170,220)(H,171,236)(H,172,237)(H,173,235)(H,174,225)(H,175,240)(H,176,228)(H,177,221)(H,178,230)(H,179,229)(H,180,223)(H,181,224)(H,182,222)(H,183,238)(H,184,239)(H,185,241)(H,186,217)(H,187,226)(H,188,231)(H,189,242)(H,190,227)(H,191,208)(H,192,232)(H,193,234)(H,194,233)(H,209,210)(H,211,212)(H,213,214)(H4,158,159,163)(H4,160,161,164)/t72-,73+,74+,75+,85-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| KEGG PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046 BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this Ligand-Target Pair | |